NovoBiome launched to revolutionize treatment of liver diseases by targeting the microbiome-gut-liver axis
First biotech company dedicated to developing breakthrough Live Biotherapeutic Products targeting the critical nexus of liver, intestinal diseases and gut microbiome Lead product focused on